283 related articles for article (PubMed ID: 8909833)
1. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Barber BA; Pegram PS; High KP
Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
[TBL] [Abstract][Full Text] [Related]
4. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
Toma E; Fournier S; Dumont M; Bolduc P; Deschamps H
Clin Infect Dis; 1993 Aug; 17(2):178-84. PubMed ID: 8399863
[TBL] [Abstract][Full Text] [Related]
5. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
[TBL] [Abstract][Full Text] [Related]
6. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
Beumont MG; Graziani A; Ubel PA; MacGregor RR
Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
[TBL] [Abstract][Full Text] [Related]
7. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.
Ruf B; Rohde I; Pohle HD
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):207-10. PubMed ID: 2060533
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
10. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
Hughes WT
Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
[TBL] [Abstract][Full Text] [Related]
11. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Korraa H; Saadeh C
South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
[TBL] [Abstract][Full Text] [Related]
12. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
Urbancic KF; Pisasale D; Wight J; Trubiano JA
Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
[TBL] [Abstract][Full Text] [Related]
13. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia.
Kim T; Kim SH; Park KH; Cho OH; Sung H; Kim MN; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
J Infect Chemother; 2009 Oct; 15(5):343-6. PubMed ID: 19856077
[TBL] [Abstract][Full Text] [Related]
14. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
15. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
Helweg-Larsen J; Benfield T; Atzori C; Miller RF
J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161
[TBL] [Abstract][Full Text] [Related]
17. Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia).
Saxena P; Muthu V; Dhooria S; Sehgal IS; Prasad KT; Agarwal R
N Z Med J; 2020 Jan; 133(1508):123-126. PubMed ID: 31945049
[TBL] [Abstract][Full Text] [Related]
18. Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients.
Nickel P; Schürmann M; Albrecht H; Schindler R; Budde K; Westhoff T; Millward J; Suttorp N; Reinke P; Schürmann D
Infection; 2014 Dec; 42(6):981-9. PubMed ID: 25168263
[TBL] [Abstract][Full Text] [Related]
19. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
[TBL] [Abstract][Full Text] [Related]
20. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
